The international conference New Frontiers in Structure-Based Drug Discovery  is jointly established by the European MSC Innovative Training Networks AEGIS and TASPPI at Convitto della Calza in Florence, Italy.


The meeting will run from 12:00 Mon, Sep 23 to  16:00, Wed, Sep 25, 2019



Download program


Joint International Conference
New Frontiers in Structure-based Drug Discovery
Monday, Sep 23, 2019                             Key note lectures: 35+5 min, Talks: 15+5 min, Flash Talk: 2 min
12:45 Welcome  Michael Sattler, Christian Ottmann
  SESSION 1 – Structure- and Fragment-based Drug Discovery
Chair: Christian Ottmann
13:00 Keynote lecture: Stephen Fesik Cancer Drug Discovery Using Fragment-Based Methods and Structure-Based Design
13:40 Francesco Bosica Mg2-assisted small-molecule stabilisation of 14-3-3 Protein-Protein Interactions.
14:00 Barak Akabayov Development of antibacterial agents that target the ribosomal PTC of M. tuberculosis
14:20 Christian Griesinger Modulation of aggregating proteins studied by NMR and beyond in neuro- and cellular degeneration
14:40 Madita Wolter Drug Discovery at the Boundary of Cancer and Infection
15:00 Keynote lecture: Mike Hann ‘PhABits – shining new light on fragment approaches for assessing target tractability'
15:40 Coffee Break
  SESSION 1 – cont'd
Chair: Tomáš Obšil
16:10 João Neves Nuclear Magnetic Resonance guided screening applied to the discovery of modulators of 14-3-3 Protein-Protein Interactions
16:30 Stefan Hoerer Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule
16:50 Keynote lecture: Edward Tate Fragment-guided discovery of an irresistible antiviral protein-protein interaction inhibitor
17:30 Flash Talks


Poster Session 1 with drinks
Tuesday, Sep 24, 2018
  SESSION 2 – Intrinsically Disordered and Amyloidogenic Proteins
Chair: Isabelle Landrieu
09:00 Keynote lecture: Birthe Kragelund Disordered Protein Complexes
09:40 Orgeta Zeijneli A VHH directed against tau as a novel therapeutic approach in tauopathies
10:00 Carlos Camacho Neuroprotection by small molecule inhibition of disordered peptide and syntaxin interaction
10:20 Coffee Break
  SESSION 3 – Chemical biology, targeting & new concepts
Chair: Alex Dömling


Keynote lecture: Alessio Ciulli Targeted Protein Degradation with Small Molecules: How PROTACs work
11:30 Felix Hausch Selective FKBP51 inhibitors enabled by transient pocket binding
11:50 Markella Konstantinidou Discovery of proteolysis targeting chimeras for leucine-rich repeat kinase 2 (LRRK2)
12:10 Nikolaos Sgourakis New tools for the analysis of polyclonal T cell repertoires using chaperone-mediated peptide exchange
12:30 Valeria Napolitano Inhibition of glycosomal protein import: the sweet death of Trypanosoma
12:50 Lunch 
  SESSION 3 – cont'd
Chair:  Alex Dömling
14:20 Keynote lecture: Michelle Arkin Chemical Biology Approaches to Understanding the VCP/p97 Protein Interaction Network
15:00 João Encarnação Bioengineering subunit B from Shiga Toxin 1 for intracellular drug delivery
  SESSION 4 – Peptides, natural products and non-small molecules
Chair: Andrew Wilson
15:20 Keynote lecture: Ora Schueler-Furman Peptide as leads for targeted inhibition of interactions – How free, how determined?
16:00 Helen Boyd Identification of a novel cyclic peptide that disrupts the homodimerization of the E3 ubiquitin ligase IDOL
16:20 Coffee Break
  SESSION 4 – cont'd
Chair: Andrew Wilson
16:50 Françoise Ochsenbein Rational Design of Peptides and Foldamers inhibiting a New Epigenetic Target in Cancer
17:10 Grzegorz Dubin Macrocycle mediated inhibition of PD-1/PD-L1 immune checkpoint
17:30 Katiuscia Pagano Design of antiangiogenic agents targeting Fibroblast Growth Factors-2/Tyrosine-Kinase Receptor
17:50 Federica De Leo Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment
18:10 Xiao-Ling Cockcroft New Paradigm for Finding Natural-product-like KRAS Inhibitors
18:30 Keynote lecture: Patricia Aducci Fusicoccin and 14-3-3 proteins, a long story from plant pathology to drug design.
Poster Session 2 
Gala Dinner
Wednesday, Sep 25, 2018
  SESSION 5 – Computational Drug Discovery
Chair: Helena Danielson
09:00 Keynote lecture: Rebecca Wade Computational Approaches to Protein Dynamics and Binding Kinetics for Drug Discovery
09:40 Marcus Gastreich Debunking a myth - Can σ-Holes Really Drive Affinity?
10:00 Alessandro Paiardini Identification of small-molecule inhibitors of the Aurora-A/TPX2 complex
  SESSION 6 – Structural biology, biophysics & methods
Chair: Michael Nilges
10:20 Sebastian Guenther Serial Crystallography for Ligand-Binding Studies
10:40 Charlotte Softley Placing fragments with lanthanide tags using paramagnetic NMR
11:00 Coffee Break
  SESSION 6 – cont'd
Chair: Michael Nilges
11:30 Claire Munier Small molecule stabilization of the GR 14-3-3 protein-protein interaction (PPI)
11:50 Daisy Paiva Because structure means function - Conformational changes in proteins measured with switchSENSE®
12:10 Charlotte Hodson Expanding Crystallographic methods for Fragment-based Drug Design
12:30 Keynote lecture: Jan Steyaert From Nanobodies to Megabodies for applications in cryo-EM
13:10 Lunch
14:40 Announcement of Posterprizes 
END/FAREWELL Michael Sattler, Christian Ottmann
Workshop BioSolveIT



MSC Innovative Training Networks AEGIS & TASPPI


Prof. Dr. Michael Sattler

Institute of Structural Biology
Helmholtz Zentrum München
Ingolstädter Landstr. 1
85764 Neuherberg

Phone: +49 (0)89 3187-3800



Prof. Christian Ottmann

Dpt. of Biomedical Engineering
Technische Universiteit Eindhoven
P.O. Box 513

Phone: +31 40-247 2835



Dr. Eva Schlosser

Institute of Structural Biology
Helmholtz Zentrum München
Ingolstädter Landstr. 1
85764 Neuherberg

Phone: +49 (0)89 3187-2908



Laura Bassani

Via Madonna del Piano, 6
50019 Sesto Fiorentino (FI), Italy

Phone: +39 055 457 4237 - 4258



We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.